Avengers: Doomsday’s $360M China Bet Points to $1B Opening

3 min read

China Could Hand Doomsday $360M

The next Avengers installment is turning China into the box-office story of the quarter. A new China poster for Avengers: Doomsday confirms a December 16 theatrical date, and early trade projections report a possible $360 million China gross. That single number would reshape the film’s worldwide opening.

Global advance ticket sales have already crossed $100 million, and the North American opening is projected above $300 million. If China delivers near the $360 million estimate, that one territory would account for more than a third of the $1 billion global opening weekend now being discussed. The film would then be in a position to match or pass the Avengers: Endgame record.

The China benchmark is not abstract

Endgame remains a live reference point. The report says it has crossed 90 million admissions in China, including Encore screenings, putting it 14th on the all-time attendance chart in that market. That is the demand profile Doomsday is being set against.

The buzz is darker, and deliberately so

Early reviews quoted in the report describe the film as “completely humorless” and a “harrowing bloodbath”. There is also chatter about a substantial superhero death toll, with the important difference from Infinity War that the dead may not be resurrected this time.

For marketers, that tone cuts both ways. It can create urgency for the first weekend, but it also means the second weekend depends on whether audiences want to sit through a brutal event again. A bloodbath sells tickets once; it does not automatically sell them twice.

What to track before December 16

  • China’s daily pre-sale velocity and IMAX screen share, since China is one of five markets screening the film in the premium format.
  • The release window around Dune: Part Three, the clearest competition named in the report.
  • Post-screening sentiment in the first 24 hours, because a humorless, high-fatality story can swing word-of-mouth quickly.

The film is reported to be the most anticipated Hollywood release of 2026 in China, ahead of Dune: Part Three and The Odyssey. But anticipation is a pre-sale force, not a guarantee of final gross.

Why planners should not lock in early

The report itself qualifies the projections: final performance will depend on audience reception, international market performance and competition from other big releases. For media planners and entertainment marketers, that means treating the $360 million China figure as a scenario to monitor, not a line item to bank. A $1 billion opening is a strong possibility, but the data that matters now is advance sales, IMAX sell-through and holdover behaviour.

The cast is doing its job. Robert Downey Jr. returns as Doctor Doom, and Chris Evans is back as Steve Rogers. The event is there. The question is whether the numbers hold beyond the opening frame.

Source: The Times of India


More numbers